| 0.6921 -0.023 (-3.2%) | 09-28 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.84 | 1-year : | 0.88 |
| Resists | First : | 0.72 | Second : | 0.75 |
| Pivot price | 0.71 |
|||
| Supports | First : | 0.67 | Second : | 0.55 |
| MAs | MA(5) : | 0.71 |
MA(20) : | 0.71  |
| MA(100) : | 0.7 | MA(250) : | 0.71 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 43.7 |
D(3) : | 49.8 |
| RSI | RSI(14): 45.8 |
|||
| 52-week | High : | 1.88 | Low : | 0.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ COCH ] has closed above bottom band by 24.5%. Bollinger Bands are 52.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.73 - 0.73 | 0.73 - 0.74 |
| Low: | 0.69 - 0.7 | 0.7 - 0.7 |
| Close: | 0.71 - 0.72 | 0.72 - 0.72 |
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.
Tue, 22 Sep 2026
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio - TMX Newsfile
Mon, 14 Sep 2026
Alta Partners reports 2.1M Envoy Medical (COCH) shares - Stock Titan
Thu, 23 Jul 2026
Envoy Medical, Inc. (COCH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - Yahoo Finance
Tue, 21 Jul 2026
EXCLUSIVE: Envoy Medical Hits Key Clinical Trial Milestone for Fully Implanted Ear Implant - Yahoo Finance
Sun, 19 Jul 2026
Price to book forward of Envoy Medical, Inc. – NASDAQ:COCH - tradingview.com
Tue, 14 Jul 2026
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Results - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 77 (M) |
| Held by Insiders | 3.841e+007 (%) |
| Held by Institutions | 40.2 (%) |
| Shares Short | 880 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.313e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -10 % |
| Return on Assets (ttm) | 919.6 % |
| Return on Equity (ttm) | -86.6 % |
| Qtrly Rev. Growth | 207000 % |
| Gross Profit (p.s.) | -18.31 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -321693 |
| Qtrly Earnings Growth | -0.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 26.34 |
| Dividend | 0 |
| Forward Dividend | 865250 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|